Correlation Between Puma Biotechnology and Novavax
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Novavax, you can compare the effects of market volatilities on Puma Biotechnology and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Novavax.
Diversification Opportunities for Puma Biotechnology and Novavax
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Puma and Novavax is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Novavax go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Novavax
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 1.04 times more return on investment than Novavax. However, Puma Biotechnology is 1.04 times more volatile than Novavax. It trades about 0.2 of its potential returns per unit of risk. Novavax is currently generating about -0.07 per unit of risk. If you would invest 279.00 in Puma Biotechnology on December 5, 2024 and sell it today you would earn a total of 60.00 from holding Puma Biotechnology or generate 21.51% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Puma Biotechnology vs. Novavax
Performance |
Timeline |
Puma Biotechnology |
Novavax |
Puma Biotechnology and Novavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Puma Biotechnology and Novavax
The main advantage of trading using opposite Puma Biotechnology and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |